Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and α1-antichymotrypsin type A allele in Alzheimer's disease

NeuroReport

Volumn 8, Issue 12, 1997, Pages 2639-2643

  Higuchi, Makoto ^a   Arai, Hiroyuki ^a   Nakagawa, Takuma ^a   Higuchi, Susumu ^b   Muramatsu, Taro ^b   Matsushita, Sachio ^b   Kosaka, Yo Ichi ^a   Itoh, Masatoshi ^c   Sasaki, Hidetada ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURIHAMA NATIONAL HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Apolipoprotein E; Glucose metabolism; Positron emission tomography; Presenilin 1; 1 antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E; BRAIN PROTEIN; DNA; FLUORINE 18; FLUORODEOXYGLUCOSE; PRESENILIN 1;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; BRAIN METABOLISM; CLINICAL ARTICLE; FEMALE; FRONTAL LOBE; GENETIC RISK; GLUCOSE UTILIZATION; HUMAN; INTRON; LEUKOCYTE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0030848710     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199708180-00001     Document Type: Article

References (19)

1. Strittmatter WJ, Saunders AM, Schmechel D et al. Proc Natl Acad Sci USA 90, 1977-1981 (1993).
2. Kamboh MI, Sanghera DK, Ferrell RE and DeKosky ST. Nature Genet 10, 486-488 (1995).
3. Muramatsu T, Matsushita S, Arai H et al. J Neural Transm 103, 1205-1210 (1996).
4. Wragg M, Hutton M, Talbot C and Alzheimer's Disease Collaborative Group. Lancet 347, 509-512 (1996).
5. Higuchi S, Muramatsu T, Matsushita S et al. Lancet 347, 1186 (1996).
6. Cutler NR, Haxby JV, Duara R et al. Ann Neurol 18, 298-309 (1985).
7. Herholz K. Alzheimer Dis Assoc Disord 9, 6-16 (1995).
8. Haxby JV, Grady CL, Koss E et al. Neurology 38, 1853-1863 (1988).
9. Chase TN, Foster NL, Fedio P et al. Ann Neurol 15, S170-174 (1984).
10. McKhann G, Drachman D, Folstein M et al. Neurology 34, 939-944 (1984).
11. Higuchi S, Matsushita S, Hasegawa Y et al. Am J Med Gen 67, 429 (1996).
12. Hutchins GD, Holden JE, Koeppe RA et al. J Cereb Blood Flow Metabol 4, 35-40 (1984).
13. Wenham PR, Price WH and Blundell G. Lancet 337, 1158-1159 (1991).
14. Reiman EM, Caselli RJ, Yun LS et al. N Engl J Med 334, 752-758 (1996).
15. Basun H, Grut M, Winblad B and Lannfelt L. Neurosci Lett 183, 32-34 (1995).
16. Frisoni GB, Govoni S, Geroldi C et al. Ann Neurol 37, 596-604 (1995).
17. Growdon JH, Locascio JJ, Corkin S et al. Neurology 47, 444-448 (1996).
18. Lehtovirta M, Soininen H, Laakso MP et al. J Neurol Neurosurg Psychiatry 60, 644-649 (1996).
19. Haines JL, Pritchard ML, Saunders AM et al. Genomics 33, 53-56 (1996).